Newsfeeds - Spark Newswire

1 minute read

Synthetic Biologics Q1 EPS $(0.03), Inline

Today, 5:49 PM

Synthetic Biologics (AMEX:SYN) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is a 76.92 percent increase over losses of $(0.13) per share from the same period last year.

SYN

10 minute read

Earnings Scheduled For May 16, 2022

By Benzinga Insights

Today, 5:49 PM

Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.

ACRX

1 minute read

Synthetic Biologics Posts Encouraging Safety Data on SYN-020 In Healthy Volunteers

By Vandana Singh

Today, 5:49 PM

Synthetic Biologics Inc (NYSE:SYN) has announced safety data from its Phase 1 multiple ascending dose (MAD) trial of SYN-020 intestinal alkaline…

SYN

4 minute read

53 Biggest Movers From Yesterday

By Lisa Levin

Today, 5:49 PM

Gainers

AFIB

3 minute read

The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings

By Shanthi Rexaline

Today, 5:49 PM

Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment during the week.

APLT

5 minute read

64 Biggest Movers From Yesterday

By Lisa Levin

Today, 5:49 PM

Gainers Kidpik Corp. (NASDAQ: PIK) shares surged 158.2% to settle at $4.75 on Thursday after the company announced a partnership with The Walt Disney Co.

AKAN

1 minute read

Earnings

Synthetic Biologics: Q4 Earnings Insights

By Benzinga Insights

Today, 5:49 PM

Synthetic Biologics (AMEX:SYN) reported its Q4 earnings results on Wednesday, March 16, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

SYN

3 minute read

The Daily Biotech Pulse: Pfizer-BioNTech Apply For Authorization Of 3rd Booster Shot, Sanofi-Seagen Strike Cancer Therapy Pact, Iovance Gets Nod For Cancer Study

By Shanthi Rexaline

Today, 5:49 PM

Here's a roundup of top developments in the biotech space over the last 24 hours.

ADAG

4 minute read

Earnings Scheduled For March 16, 2022

By Benzinga Insights

Today, 5:49 PM

Companies Reporting Before The Bell • Ideanomics (NASDAQ:IDEX) is likely to report quarterly loss at $0.05 per share on revenue of $33.20 million.

AKU

4 minute read

The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb’s Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings

By Shanthi Rexaline

Today, 5:49 PM

Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments served as catalysts during the week.

ACIU